Boston Scientific
BSX
NYSE
IPO1992
about BSX
Boston Scientific develops medical technologies, particularly in cardiovascular care, offering products such as stents and pacemakers to treat heart conditions and enhance patient outcomes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $108.00 | $108.07 | $104.06 | $160.24B | 4.32M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.54 | 68.55 | 30.75 | 16.18% | 15.71% | 0% |